What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Disease
Amy P. Abernethy mainly focuses on Palliative care, Internal medicine, Physical therapy, Randomized controlled trial and Quality of life.
Amy P. Abernethy has included themes like Intensive care and Family medicine in her Palliative care study.
In her study, which falls under the umbrella issue of Internal medicine, Advanced cancer, Stage and Alternative medicine is strongly linked to Oncology.
The study incorporates disciplines such as Quality of life, Epidemiology and Etiology in addition to Physical therapy.
Her Randomized controlled trial study combines topics in areas such as Visual analogue scale, Anesthesia, Clinical trial and Performance status.
Amy P. Abernethy usually deals with Quality of life and limits it to topics linked to Intensive care medicine and Disease.
Her most cited work include:
- American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care (888 citations)
- Generalist plus Specialist Palliative Care — Creating a More Sustainable Model (743 citations)
- Mobile health technology evaluation: The mHealth evidence workshop (547 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Palliative care, Internal medicine, Nursing, Cancer and Intensive care medicine.
Her Palliative care research is multidisciplinary, incorporating elements of Psychological intervention, Randomized controlled trial, Family medicine and Quality of life.
Her Randomized controlled trial study frequently draws connections to other fields, such as Anesthesia.
Her Internal medicine research integrates issues from Surgery and Oncology.
Her studies in Nursing integrate themes in fields like Quality and Quality management.
In Cancer, Amy P. Abernethy works on issues like Physical therapy, which are connected to Performance status.
She most often published in these fields:
- Palliative care (50.06%)
- Internal medicine (26.18%)
- Nursing (25.54%)
What were the highlights of her more recent work (between 2015-2019)?
- Internal medicine (26.18%)
- Oncology (13.92%)
- Palliative care (50.06%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Internal medicine, Oncology, Palliative care, Cancer and Clinical trial.
Her work on Lung cancer, Retrospective cohort study, Cohort and Quality of life as part of general Internal medicine study is frequently linked to In patient, bridging the gap between disciplines.
Amy P. Abernethy combines subjects such as Physical therapy and Disease with her study of Quality of life.
Her biological study spans a wide range of topics, including Grief, Family medicine and Intensive care medicine.
Her work deals with themes such as Randomized controlled trial, Melanoma and Medical physics, which intersect with Clinical trial.
Her studies deal with areas such as Visual analogue scale, Anesthesia and Adverse effect as well as Randomized controlled trial.
Between 2015 and 2019, her most popular works were:
- Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials (275 citations)
- Prevalence and Predictors of Burnout Among Hospice and Palliative Care Clinicians in the U.S. (103 citations)
- Development and Validation of a High-Quality Composite Real-World Mortality Endpoint (65 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Internal medicine, Oncology, Clinical trial, Palliative care and Lung cancer are her primary areas of study.
While the research belongs to areas of Oncology, Amy P. Abernethy spends her time largely on the problem of Nivolumab, intersecting her research to questions surrounding Surgery.
Her study in Clinical trial is interdisciplinary in nature, drawing from both Cancer, Precision medicine, Randomized controlled trial and Melanoma.
Her work on Advance care planning as part of general Palliative care research is often related to Context, thus linking different fields of science.
Her work in Lung cancer tackles topics such as Survival analysis which are related to areas like Mortality rate, Bevacizumab, Anaplastic lymphoma kinase and Maintenance therapy.
Her work in Quality of life covers topics such as Physical therapy which are related to areas like COPD, Cross-sectional study, Young adult and Epidemiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
